Rs 150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

Recruitment for clinical trial of Covaxin in 6-12 age group to start at AIIMS from June 15

US FDA rejects emergency authorisation for Covaxin, ‘recommends’ to take full approval route

US FDA rejects emergency authorisation for Covaxin, ‘recommends’ to take full approval route

Covishield produces more antibodies than Covaxin, finds study

Why start vaccination centres with pomp if 2nd jab of COVAXIN not available, HC asks Delhi govt

Will students administered with Covaxin be allowed to travel abroad?

Indian Immunologiclas to start drug substance production for Covaxin from June

Bharat Biotech submits new request to Brazilian regulator on GMP issues for Covaxin

K’taka’s global tender for vaccines get response from 2 firms to supply Sputnik

Bharat Biotech’s US partner Ocugen submits ‘Master File’ to FDA on Covaxin

WHO says ‘more information’ required from Bharat Biotech for emergency use listing of Covaxin

Paediatric trials of Covaxin may begin in June: Bharat Biotech official

Wastage of Covaxin down to 4% from 17% in March and Covishield from 8% to 1%: Govt

Govt exploring possibility of Covaxin production outside India

Karnataka receives 2,00,000 doses of Covishield: Dr K Sudhakar

Covaxin clinical trials in children between 2-18 years to begin in 10-12 Days: Centre

‘Bharat Biotech’s K’taka facility will have capacity to make 4-5 cr doses of Covaxin a month by August-end’

Covaxin effective against India, UK coronavirus strains: Bharat Biotech

Kolar: Covaxin manufacturing unit to be set up in Malur

DCGI approves Phase 2, 3 clinical trials of Bharat Biotech’s Covaxin for 2 -18 year-olds

Bharat Biotech says can’t provide additional Covaxin doses to Delhi: Sisodia

Experts recommend Covaxin for phase 2/3 trials on those aged 2-18 year

18 states getting direct supply of Covaxin since May 1, says Bharat Biotech

Fact Check: Did government approve Bharat Biotech’s Covaxin for children above 12 years?

SC directs Centre to revisit current vaccine policy, says it may create disparity

Over 79L COVID-19 vaccine doses available with States/UTs, says Centre

Bharat Biotech seeks DCGI’s nod to extend shelf life of Covaxin

Over 21k tested positive for COVID after taking first dose of either Covishield or Covaxin: Govt

Covaxin neutralises double mutant strain: ICMR

Noted Tamil comic actor Vivek no more

Mumbai’s Haffkine Institute gets Centre’s nod to produce Covaxin

Supplied more vaccines globally than having vaccinated our own people, India tells UN

Nepal gives emergency use approval to Bharat Biotech’s Covaxin

Latest Additions

In Kuwait, PM Modi meets yoga practitioner, other influencers from Gulf country

Notorious gangster wanted in UAPA case arrested at Nepal border

Mandhana, Renuka blow away West Indies in first ODI

‘Condition critical’, say doctors as farmer leader Dallewal’s fast enters 27th day

ISRO to study how crops grow in space on PSLV-C60 mission

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.